Xenon Pharmaceuticals USA Inc. has 5 H-1B filings in Massachusetts with $144,560 avg salary. 100% approval rate.
In Massachusetts, Xenon Pharmaceuticals USA Inc. has sponsored 5 H-1B positions at an average compensation of $145k. The most common roles are Manager, Commercial Analytics (40%), Associate Director, CMC, Analytical Development (20%), Research Scientist 2, Computational Chemistry (20%). 100% of petitions were certified, with an average processing time of 8 days. Salaries range from $105k to $200k. 20% of positions are for new employment.
| Total Filings | 5 |
| Approval Rate | 100% |
| Average Salary | $144,560 |
| Median Salary | $140,000 |
| 25th Percentile | $137,800 |
| 75th Percentile | $140,000 |
| Minimum Salary | $105,000 |
| Maximum Salary | $200,000 |
| Percentile | Salary |
|---|---|
| 10th | $105k |
| 25th | $138k |
| 50th (Median) | $140k |
| 75th | $140k |
| 90th | $200k |
Based on 5 salary records. Range: $105k – $200k.
100% of filings offer salaries above the prevailing wage, with an average premium of 23.6%. The average prevailing wage is $116k (based on 5 filings with prevailing wage data).
Average processing time is 8 days (median: 7 days). Fastest: 7 days, slowest: 10 days. Based on 5 filings.
20% of filings are for new positions, while 0% are for continued employment (5 filings with data).
Average contract duration: 36 months (median: 36 months), based on 5 filings.
| Education Level | Filings |
|---|---|
| Not Specified | 5 |
| Job Title | Filings |
|---|---|
| Manager, Commercial Analytics | 2 |
| Associate Director, CMC, Analytical Development | 1 |
| Research Scientist 2, Computational Chemistry | 1 |
| Biostatician | 1 |
Xenon Pharmaceuticals USA Inc. has 5 H-1B filings in Massachusetts in our database of DOL public records.
The average H-1B salary at Xenon Pharmaceuticals USA Inc. in Massachusetts is $144,560, with a median of $140,000. Salaries range from $105,000 to $200,000.
Xenon Pharmaceuticals USA Inc.'s H-1B approval rate in Massachusetts is 100% based on 5 DOL filings.